Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
A new antibody therapy eliminated detectable multiple myeloma in all 18 trial patients, showing potential for a functional cure.
A new antibody therapy, linvoseltamab, showed promising results in treating multiple myeloma, a blood cancer, in an early trial of 18 patients.
After up to six treatment cycles, no detectable cancer was found in any participant, according to highly sensitive tests.
The bispecific antibody links T cells to myeloma cells by targeting CD3 and BCMA, boosting the immune system’s attack on the disease.
Researchers called the outcomes “extremely impressive,” suggesting the treatment may eliminate the need for bone marrow transplants and offer long-term control, possibly a functional cure.
Side effects like neutropenia and respiratory infections were manageable.
The findings were presented at the American Society of Hematology meeting, but larger trials are needed to confirm results.
Una nueva terapia de anticuerpos eliminó el mieloma múltiple detectable en todos los 18 pacientes del ensayo, mostrando potencial para una curación funcional.